Home Cart Sign in  
Chemical Structure| 1331782-27-4 Chemical Structure| 1331782-27-4

Structure of PF-04995274
CAS No.: 1331782-27-4

Chemical Structure| 1331782-27-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF-04995274 is a selective 5-HT4 receptor partial agonist that can improve cognitive function.

Synonyms: PF-4995274

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PF-04995274

CAS No. :1331782-27-4
Formula : C23H32N2O6
M.W : 432.51
SMILES Code : OC1(CN2CCC(COC3=NOC4=C3C(O[C@H]5COCC5)=CC=C4)CC2)CCOCC1
Synonyms :
PF-4995274
MDL No. :MFCD29079009

Safety of PF-04995274

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of PF-04995274

GPCR

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
129S6/SvEv mice Chronic corticosterone (CORT) model and contextual fear conditioning (CFC) Injection 3 or 10 mg/kg Single injection, CFC performed 1 week later PF-04995274 at 10 mg/kg attenuated learned fear and decreased stress-induced depressive-like behavior PMC6969048
129S6/SvEv mice Chronic corticosterone (CORT) model and contextual fear conditioning (CFC) Injection 3 or 10 mg/kg Single injection, followed by CFC one week later PF-04995274 at 10 mg/kg attenuated learned fear and decreased stress-induced depressive-like behavior. PMC6969048

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01173757 Healthy PHASE1 COMPLETED 2025-11-10 Pfizer Investigational Site, N... More >>ew Haven, Connecticut, 06511, United States|Pfizer Investigational Site, New Haven, Connecticut, 06519, United States|Pfizer Investigational Site, New Haven, Connecticut, 06520, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.31mL

0.46mL

0.23mL

11.56mL

2.31mL

1.16mL

23.12mL

4.62mL

2.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories